Explore our pipeline of therapies targeting underserved areas of ophthalmology:
- OCU300For ocular graft versus host disease (oGVHD)
- OCU400For treatment of NR2E3 mutation-associated retinal degeneration
- OCU200For wet age-related macular degeneration
Addressing a common complication that occurs in about 60% of patients who have undergone allogeneic hemotological stem cell transplantation, or bone marrow transplants.

Addressing a common yet under-diagnosed ocular disorder that affects millions of adults in the US and its prevalence increases with age.
Learn More About OCU310Addressing a range of genetically diverse inherited degenerative retinal diseases.
Learn More About OCU400Addressing a group of inherited diseases that cause progressive retinal degeneration, affecting approximately 100,000 people in the US and similar number in Europe.
Learn More About OCU100Addressing the leading cause of vision loss in people over the age of 60, where abnormal blood vessels grow under the retina and leak blood and proteins.
Learn More About OCU200Press Releases
Explore our pipeline of therapies targeting underserved areas of ophthalmology:
Addressing a range of genetically diverse inherited degenerative retinal diseases.
Learn More About OCU400